170 related articles for article (PubMed ID: 22053827)
1. Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein.
Zanotto C; Pozzi E; Pacchioni S; Bissa M; De Giuli Morghen C; Radaelli A
J Transl Med; 2011 Nov; 9():190. PubMed ID: 22053827
[TBL] [Abstract][Full Text] [Related]
2. The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response.
Bissa M; Zanotto C; Pacchioni S; Volonté L; Venuti A; Lembo D; De Giuli Morghen C; Radaelli A
Antiviral Res; 2015 Apr; 116():67-75. PubMed ID: 25660110
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins.
Pozzi E; Basavecchia V; Zanotto C; Pacchioni S; Morghen Cde G; Radaelli A
J Virol Methods; 2009 Jun; 158(1-2):184-9. PubMed ID: 19428588
[TBL] [Abstract][Full Text] [Related]
4. Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.
Aires KA; Cianciarullo AM; Carneiro SM; Villa LL; Boccardo E; Pérez-Martinez G; Perez-Arellano I; Oliveira ML; Ho PL
Appl Environ Microbiol; 2006 Jan; 72(1):745-52. PubMed ID: 16391114
[TBL] [Abstract][Full Text] [Related]
5. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
6. L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.
Pacchioni SM; Bissa M; Zanotto C; Morghen Cde G; Illiano E; Radaelli A
J Transl Med; 2013 Apr; 11():95. PubMed ID: 23578094
[TBL] [Abstract][Full Text] [Related]
7. Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X.
Illiano E; Bissa M; Paolini F; Zanotto C; De Giuli Morghen C; Franconi R; Radaelli A; Venuti A
Virus Res; 2016 Oct; 225():82-90. PubMed ID: 27664839
[TBL] [Abstract][Full Text] [Related]
8. A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers.
Bissa M; Illiano E; Pacchioni S; Paolini F; Zanotto C; De Giuli Morghen C; Massa S; Franconi R; Radaelli A; Venuti A
J Transl Med; 2015 Mar; 13():80. PubMed ID: 25763880
[TBL] [Abstract][Full Text] [Related]
9. GFP co-expression reduces the A33R gene expression driven by a fowlpox vector in replication permissive and non-permissive cell lines.
Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Radaelli A
J Virol Methods; 2013 Jan; 187(1):172-6. PubMed ID: 23000750
[TBL] [Abstract][Full Text] [Related]
10. Canarypox and fowlpox viruses as recombinant vaccine vectors: an ultrastructural comparative analysis.
Pacchioni S; Volonté L; Zanotto C; Pozzi E; De Giuli Morghen C; Radaelli A
Arch Virol; 2010 Jun; 155(6):915-24. PubMed ID: 20379750
[TBL] [Abstract][Full Text] [Related]
11. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
Matić S; Rinaldi R; Masenga V; Noris E
BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry.
Hindmarsh PL; Laimins LA
Virol J; 2007 Feb; 4():19. PubMed ID: 17324266
[TBL] [Abstract][Full Text] [Related]
13. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.
Sanchooli A; Aghaiypour K; Kiasari BA; Samarbaf-Zadeh A; Ghadiri A; Makvandi M
Protein Pept Lett; 2018; 25(8):783-790. PubMed ID: 30091403
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
[TBL] [Abstract][Full Text] [Related]
15. Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.
Waheed MT; Thönes N; Müller M; Hassan SW; Razavi NM; Lössl E; Kaul HP; Lössl AG
Transgenic Res; 2011 Apr; 20(2):271-82. PubMed ID: 20563641
[TBL] [Abstract][Full Text] [Related]
16. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
[TBL] [Abstract][Full Text] [Related]
17. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.
Fleury MJ; Touzé A; Coursaget P
Mol Biotechnol; 2014 May; 56(5):479-86. PubMed ID: 24639327
[TBL] [Abstract][Full Text] [Related]
19. Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits.
Radaelli A; Pozzi E; Pacchioni S; Zanotto C; Morghen Cde G
J Transl Med; 2010 Apr; 8():40. PubMed ID: 20409340
[TBL] [Abstract][Full Text] [Related]
20. HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer.
Namvar A; Bolhassani A; Hashemi M
Bratisl Lek Listy; 2016; 117(3):179-84. PubMed ID: 26925750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
